Alliance for Regenerative Medicine

Alliance for Regenerative Medicine

ATIVESITE | Delivering cell and gene therapies to patients: ARM Studios interview with Jason Foster

How do we get cell therapies to patients? ARM CEO Tim Hunt sits down with Jason Foster, CEO of Ori Biotech, at ARM Studios to outline his vision for launching…

Read More »

ATIVESITE | Andelyn Biosciences

Andrew Moreo, Ph.D., Head of Process Development Viral Vector Core Columbus, OH (Private) Source Alliance for Regenerative Medicine YouTube

Read More »

ATIVESITE | Presentation on the Med during the Alliance for Regenerative Medicine Meeting (April 2022)

Presentation made by our CEO Eric Halioua during during the “Cell & Gene Meeting on the Med 2022” conference organized in Barcelona (Spain) by Alliance for Regenerative Medicine in April…

Read More »

ATIVESITE | FIRESIDE CHAT: LUCY ELLERKER, FOUNDER, OPIE JONES FOUNDATION

Chair: Bob Smith, Vice-Chair, Alliance for Regenerative Medicine (ARM) Speaker: Lucy Ellerker-Jones, Founder, Opie Jones Foundation Source Alliance for Regenerative Medicine YouTube

Read More »

ATIVESITE | Opportunities for impact in cell therapy: ARM Studios interview with Miguel Forte

What is driving the passion behind innovations and breakthroughs in cell therapy? Rita Johnson-Greene, ARM’s COO, sits down with Kiji Therapeutics CEO Miguel Forte to discuss his organization’s work and…

Read More »

ATIVESITE | Presentation on the Mesa during the Alliance for Regenerative Medicine Meeting ( October 2020 )

Presentation made by our CEO Eric Halioua during the Alliance for Regenerative Medicine Meeting on the Mesa organized in October 2020 Eric presents the company strategy, the clinical strategy and…

Read More »

ATIVESITE | Accelerating cell and gene therapies for rare diseases: ARM Studios interview with Julia Jenkins

The cost of living with a rare disease is often overlooked when weighing the impact of cell and gene therapies. Stephen Majors, ARM’s Global Head of Communications, sits down with…

Read More »

ATIVESITE | Patient ethics in cell and gene therapy: ARM Studios interview with Durhane Wong-Rieger

What ethical challenges confront the cell and gene therapy sector? ARM CEO Tim Hunt and Canadian Organization for Rare Disorders president and CEO Durhane Wong-Rieger discuss the patient perspective. #cellandgenetherapy…

Read More »

ATIVESITE | ARM’s 2022 Cell & Gene State of the Industry Briefing

The Alliance for Regenerative Medicine’s annual Cell & Gene State of the Industry Briefing, a top-level gathering for key stakeholders in the field. This webinar includes ARM’s annual yearly update…

Read More »

ATIVESITE | Viacyte

Kevin D’Amour, Ph.D., Chief Scientific Officer and VP, Research San Diego, CA (Private) Source Alliance for Regenerative Medicine YouTube

Read More »